Veradermics, Inc
MANE$1.56B
Small CapNASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Aug 15, 2026
22wMarket Overview
Stock performance and key metrics
MANE News
Catalyst Timeline
2 upcoming, 1 past
Drug Pipeline
VDPHL01
Androgenetic Alopecia
VDPHL01 QD
Androgenetic Alopecia (AGA)
VDMN-21 Patch Low Dose
Verruca Vulgaris
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
VDPHL01 | Phase 3 | Androgenetic Alopecia | - | - |
VDPHL01 QD | Phase 3 | Androgenetic Alopecia (AGA) | - | - |
VDMN-21 Patch Low Dose | Phase 2 | Verruca Vulgaris | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply